Healthy VolunteersNeuroimaging & Brain MeasuresDMT

Brain substates induced by DMT relate to sympathetic output and meaningfulness of the experience

Using simultaneous fMRI and EKG in 14 volunteers, the study identifies a DMT‑induced brain substate—hippocampal and medial parietal deactivation with increased superior temporal activity—linked to altered sense of time/space/self and vivid audio‑visual “entities”. Increased heart rate covaried with these deactivations and the experience of entities, suggesting a chain from sympathetic activation to specific neural and phenomenological effects that may relate to therapeutic changes in self‑referential processing.

Authors

  • Robin Carhart-Harris
  • Christopher Timmermann
  • Leor Roseman

Published

Biorxiv
individual Study

Abstract

N,N-Dimethyltryptamine (DMT) is a serotonergic psychedelic, known to rapidly induce short-lasting alterations in conscious experience, characterized by a profound and immersive sense of physical transcendence alongside rich and vivid auditory distortions and visual imagery. Multimodal neuroimaging data paired with dynamic analysis techniques offer a valuable approach for identifying unique signatures of brain activity – and linked autonomic physiology – naturally unfolding during the altered state of consciousness induced by DMT. We leveraged simultaneous fMRI and EKG data acquired in 14 healthy volunteers prior to, during, and after intravenous administration of DMT, and, separately, placebo. fMRI data was preprocessed to derive individual dynamic activity matrices, reflecting the similarity of brain activity in time, and community detection algorithms were applied on these matrices to identify brain activity substates; EKG data was used to derive continuous heart rate. We identified a brain substate occurring immediately after DMT injection, characterized by hippocampal and medial parietal deactivations and increased superior temporal lobe activity under DMT. Deactivations in the hippocampus and medial parietal cortex correlated with alterations in the usual sense of time, space and self-referential processes, reflecting a deconstruction of essential features of ordinary consciousness. Superior lobe activations instead correlated with audio/visual hallucinations and experience of “ entities ”, reflecting the emergence of altered sensory experiences under DMT. Finally, increased heart rate under DMT correlated positively with hippocampus/medial parietal deactivation and the experience of “ entities ”, and negatively with altered self-referential processes. These results suggest a chain of influence linking sympathetic regulation to hippocampal and medial parietal deactivations under DMT, which combined, may contribute to positive mental health outcomes related to self-referential processing following psychedelic administration.

Available with Blossom Pro

Research Summary of 'Brain substates induced by DMT relate to sympathetic output and meaningfulness of the experience'

Introduction

Pasquini and colleagues situate this study in the context of two complementary aspects of selfhood: a bodily or interoceptive self that depends on integration of autonomic and visceral signals, and a narrative self that depends on medial temporal and midline parietal structures associated with autobiographical memory and self-referential thought (the default mode network, DMN). They note that serotonergic psychedelics such as N,N-dimethyltryptamine (DMT) produce a rapid, short-lasting but intense alteration of consciousness with pronounced sensory immersion and changes in autonomic physiology, particularly transient increases in sympathetic tone measured via heart rate. Earlier neuroimaging studies of psychedelics have reported global connectivity changes and DMN disruptions, but the authors argue that the fast dynamics of intravenous DMT make it a useful probe for studying temporally evolving brain states and linked peripheral physiology using dynamic analysis methods applied to simultaneous fMRI and electrocardiogram (EKG) recordings. The study therefore aims to identify time-resolved brain activity ‘‘substates’’ that differentiate DMT from placebo and to link those substates to autonomic indices and subjective reports. Specifically, the investigators apply dynamic similarity-matrix analyses and graph-theoretical community detection to resting-state fMRI acquired with concurrent EKG in a within-subject, placebo-controlled design, to characterise the natural progression of neural and cardiac signatures unfolding immediately before, during, and after intravenous DMT administration. The goal is to test whether distinct substates arise under DMT, how long they persist, and whether substate-specific regional activations or deactivations relate to auditory distortions, ego-dissolution, meaningfulness of the experience, and heart-rate changes.

Expert Research Summaries

Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.

Full Text PDF

Full Paper PDF

Pro members can view the original manuscript directly in the browser.

Study Details

References (25)

Papers cited by this study that are also in Blossom

DMT alters cortical travelling waves

Alamia, A., Timmermann, C., Carhart-Harris, R. L. · eLife (2020)

The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs

Carhart-Harris, R. L., Leech, R., Shanahan, M. et al. · Frontiers in Human Neuroscience (2014)

Neural correlates of the LSD experience revealed by multimodal neuroimaging

Carhart-Harris, R. L., Muthukumaraswamy, S., Roseman, L. et al. · PNAS (2016)

Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin

Carhart-Harris, R. L., Erritzoe, D., Williams, T. et al. · PNAS (2012)

492 cited
Psychedelics and the essential importance of context

Carhart-Harris, R. L., Roseman, L., Haijen, E. C. H. M. et al. · Journal of Psychopharmacology (2018)

Constructing drug effects: a history of set and setting

Hartogsohn, I. · Drug Science Policy and Law (2017)

389 cited
Phenomenology and Content of the Inhaled N, N-Dimethyltryptamine (N, N-DMT) Experience

Lawrence, D. W., Carhart-Harris, R. L., Griffiths, R. R. et al. · Research Square (2022)

Finding the self by losing the self: Neural correlates of ego-dissolution under psilocybin

Lebedev, A. V., L€ Ovd En, M., Rosenthal, G. et al. · Human Brain Mapping (2015)

Me, myself, bye: regional alterations in glutamate and the experience of ego dissolution with psilocybin

Mason, N. L., Kuypers, K. P. C., Reckweg, J. et al. · Neuropsychopharmacology (2020)

Show all 25 references
Psychedelic Resting-state Neuroimaging: A Review and Perspective on Balancing Replication and Novel Analyses

McCulloch, D. E-W., Knudsen, G. M., Barrett, F. S. et al. · Neuroscience and Biobehavioral Reviews (2022)

Broadband Cortical Desynchronization Underlies the Human Psychedelic State

Muthukumaraswamy, S. D., Carhart-Harris, R. L., Moran, R. J. et al. · Journal of Neuroscience (2013)

427 cited
The psychedelic state induced by ayahuasca modulates the activity and connectivity of the default mode network

Palhano-Fontes, F., Andrade, K. C., Tófoli, L.F. et al. · PLOS ONE (2015)

The Altered States Database: Psychometric data from a systematic literature review

Prugger, J., Derdiyok, E., Dinkelacker, J. et al. · Scientific Data (2022)

The entropic heart: Tracking the psychedelic state via heart rate dynamics

Rosas, F. E., Mediano, P. A. M., Timmermann, C. et al. · Biorxiv (2023)

Quality of acute psychedelic experience predicts therapeutic efficacy of psilocybin for treatment-resistant depression

Roseman, L., Nutt, D. J., Carhart-Harris, R. L. · Frontiers in Pharmacology (2018)

Psilocybin desynchronizes brain networks

Nicol, G. E. · Nature (2024)

160 cited
Increased global functional connectivity correlates with LSD-induced ego dissolution

Tagliazucchi, E., Roseman, L., Kaelen, M. et al. · Current Biology (2016)

Human brain effects of DMT assessed via EEG-fMRI

Timmermann, C., Roseman, L., Haridas, S. et al. · PNAS (2023)

158 cited
Neural correlates of the DMT experience assessed with multivariate EEG

Timmermann, C., Roseman, L., Schartner, M. et al. · Scientific Reports (2019)

Acute effects of intravenous DMT in a randomized placebo-controlled study in healthy participants

Vogt, S. B., Ley, L., Erne, L. et al. · Translational Psychiatry (2023)

64 cited
The neurobiology of psychedelic drugs: implications for the treatment of mood disorders

Vollenweider, F. X., Kometer, M. · Nature Reviews Neuroscience (2010)

Learning to Let Go: A Cognitive-Behavioral Model of How Psychedelic Therapy Promotes Acceptance

Wolff, M., Evens, R., Mertens, L. J. et al. · Frontiers in Psychiatry (2020)

The Subjective Effects of Psychedelics Are Necessary for Their Enduring Therapeutic Effects

Yaden, D. B., Griffiths, R. R. · ACS Pharmacology and Translational Science (2020)

Cited By (1)

Papers in Blossom that reference this study

Your Personal Research Library

Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.

Brain substates induced by DMT relate to... — Research Summary & Context | Blossom